which glp-1 medication is best for weight loss Women: Benefits, Results & Safety World Health Organization issues first-ever

The primary mechanisms of action include: Enhancing insulin secretion from the pancreas in response to elevated blood glucose levels, which helps lower blood sugar Suppressing glucagon release , a hormone that raises blood glucose Slowing gastric emptying , which means food moves more slowly from the stomach into the small intestine Reducing appetite through effects on brain centres that regulate hunger and satiety These combined effects make GLP-1 receptor agonists effective for glycaemic control in type 2 diabetes and, for those specifically licensed for weight management, achieving significant weight loss

Existing extended-release options, like weekly formulations of semaglutide and dulaglutide, have reduced injection frequency, and future innovations may include monthly formulations or implantable devices that deliver continuous therapy

Epidemiological and genetic data are supportive

Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for type 2 diabetes and obesity, have evolved into multi-organ potential therapeutics due to their pleiotropic effects beyond glycemic control

E., Aukrust P., Farup P

The drugs appeared to specifically target the motivational drive to seek rewarding substances